Drew Hansen will provide support to AFT SA, bringing a decade of global pharmaceutical business development expertise with Edge Pharmaceuticals. He specialises in international expansion, licensing, and strategic partnerships, with a strong track record across Europe, the U.S., Africa, Asia-Pacific, and emerging markets.
Drew’s analytical expertise underpins the identification of high-growth opportunities and guides the company’s strategic direction and global portfolio decisions. He leads complex negotiations and drives commercialisation strategies across multiple markets.
Drew’s cross-functional leadership and global regulatory insight will support AFT SA’s growth and integration into South Africa’s pharmaceutical landscape.

